By Dr. David Limauro | Posted: Monday, April 4, 2016 12:06 pm
AL Pitt Gastro
#mc_embed_signup{background:#fff; clear:left; font:14px Helvetica,Arial,sans-serif; } /* Add your own MailChimp form style overrides in your site stylesheet or in this style block. We recommend moving this block and the preceding CSS link to the HEAD of your HTML file. */
Subscribe to our maili...
Read More
The Importance of a Full Workup for GERD Patients
Dr. Tsai reviews the various tests that chronic heartburn or gastroesophageal reflux disease (GERD) sufferers can take to determine the root cause of their symptoms.
(function(i,s,o,g,r,a,m){i['GoogleAnalyticsObject']=r;i[r]=i[r]||function(){
(i[r].q=i[r].q||[]).push(arguments)},i[r].l=1*new Date();a=s.createElement(o),
m=s.getElementsByTagName(o)[0];a.async=1;a.src=g;m.parentNode...
Read More
Tony D.
As a kid growing up, starting at the age of 9 in 1980, I started to get this burning sensation in my chest and throat. I thought it was normal. I remember telling my Dad about it and he gave me Rolaids. Interestingly, he seemed always to have Rolaids on him. Thinking back, he probably suffered from recurring heartburn as well.
I would get heartburn at least twice a week, every week and this con...
Read More
Heartburn Medicine Linked to Chronic Kidney Disease Risk, Study Shows
NBC Nightly News with Lester Holt
(function(i,s,o,g,r,a,m){i['GoogleAnalyticsObject']=r;i[r]=i[r]||function(){
(i[r].q=i[r].q||[]).push(arguments)},i[r].l=1*new Date();a=s.createElement(o),
m=s.getElementsByTagName(o)[0];a.async=1;a.src=g;m.parentNode.insertBefore(a,m)
})(window,document,'script','https://www.google-analytics.com/analytics.js','ga');
ga('create', 'UA-8301260...
Read More
Long-Term Benefits of Smoking Cessation on Gastroesophageal Reflux Disease and Health-Related Quality of Life
Published: February 4, 2016 | DOI: 10.1371/journal.pone.0147860
Abstract
Objective
Smoking is associated with gastroesophageal reflux disease (GERD). Varenicline, a nicotinic receptor partial agonist, is used to aid smoking cessation. The purpose of this study was to prospectively
examine the long-term benefits of smoking cessation on GERD and health-related quality of life (HR-QOL).
...
Read More
Chronic gastroesophageal reflux disease shares genetic background with esophageal adenocarcinoma and Barrett’s esophagus
Puya Gharahkhani1,* Joyce Tung3, David Hinds3, Aniket Mishra1,4 Barrett's and Esophageal Adenocarcinoma Consortium (BEACON), Thomas L. Vaughan5, David C. Whiteman2 and Stuart MacGregor1 on behalf of the BEACON study investigators
Author Affiliations
1Statistical Genetics Laboratory
2Cancer Control, QIMR Berghofer Medical Research Institute, Brisbane, QLD 4029, Australia
323andMe, Mount...
Read More
Reflux Revisited
January 19, 2016
Published by 23andMe under 23andMe Research, Uncategorized
A recently published study by scientists at Australia’s QIMR Berghofer Medical Research Institute could have a significant
impact on the study of esophageal adenocarcinoma, a rare but lethal form of cancer.
Along with esophageal cancer, the study looked at two other conditions that often are overlapping o...
Read More
Proton pump inhibitors alter the composition of the gut microbiota
Abstract
Objective Proton pump inhibitors (PPIs) are drugs used to suppress gastric acid production and treat GI disorders such as peptic ulcers and gastro-oesophageal reflux. They have been considered low risk, have been widely adopted, and are often over-prescribed. Recent studies have identified an increased risk of enteric and other infections with their use. Small studies have identif...
Read More
American Medical Association Creates New Category 1 Code for Torax Medical’s LINX Procedure to Treat Gastroesophageal Reflux Disease
November 18, 2015 05:00 AM Eastern Standard Time
ST. PAUL, Minn.--(BUSINESS WIRE)--Torax Medical, Inc., a leader in therapeutic interventions for sphincter-related diseases, including gastroesophageal reflux disease (GERD), announced today the American Medical Association (AMA) has created a new Category 1 Current Procedural Terminology (CPT®) Code for esophageal sphincter augmentation using ...
Read More
Study: Long-Term Outcomes of Patients Receiving a Magnetic Sphincter Augmentation Device for Gastroesophageal Reflux
Abstract
Background & Aims
Based on results from year 2 of a 5-year trial, in 2012 the US Food and Drug Administration approved the use of a magnetic device to augment lower esophageal sphincter function in patients with gastroesophageal reflux disease (GERD). We report the final results of 5 years of follow-up evaluation of patients who received this device.
Methods
We performed a prosp...
Read More